Enhanced enzymatic production of cholesteryl 6ʹ-acylglucoside impairs lysosomal degradation for the intracellular survival of Helicobacter pylori

por Muthusamy, Sasikala, Jan, Hau-Ming, Hsieh, Ming-Yen, Mondal, Soumik, Liu, Wen-Chun, Ko, Yi-An, Yang, Wei-Yuan, Mong, Kwok-Kong Tony, Chen, Guang-Chao, Lin, Chun-Hung
Publicado 2021

Abbott RealTime HBV Assay Is More Sensitive in Detection of Low Viral Load and Little Impacted by Drug Resistant Mutation in Chronic Hepatitis B Patients under Nucleot(s)ide Analog...

por Yeh, Ming-Lun, Huang, Chung-Feng, Huang, Ching-I, Liu, Shu-Fen, Yang, Hua-Ling, Hsieh, Ming-Yen, Huang, Jee-Fu, Dai, Chia-Yen, Chuang, Wan-Long, Yu, Ming-Lung
Publicado 2014

The impact of an additional extra-hepatic primary malignancy on the outcomes of patients with hepatocellular carcinoma

por Yeh, Ming-Lun, Huang, Ching-I, Huang, Chung-Feng, Hsieh, Ming-Yen, Lin, Zu-Yau, Huang, Jee-Fu, Dai, Chia-Yen, Yu, Ming-Lung, Chen, Shinn-Cherng, Chuang, Wan-Long
Publicado 2017

A Systematic Study of the Stability, Safety, and Efficacy of the de novo Designed Antimicrobial Peptide PepD2 and Its Modified Derivatives Against Acinetobacter baumannii

por Chen, Sung-Pang, Chen, Eric H-L, Yang, Sheng-Yung, Kuo, Pin-Shin, Jan, Hau-Ming, Yang, Tsai-Chen, Hsieh, Ming-Yen, Lee, Kung-Ta, Lin, Chun-Hung, Chen, Rita P-Y
Publicado 2021

Corrigendum: A Systematic Study of the Stability, Safety, and Efficacy of the de novo Designed Antimicrobial Peptide PepD2 and Its Modified Derivatives Against Acinetobacter bauman...

por Chen, Sung-Pang, Chen, Eric H-L, Yang, Sheng-Yung, Kuo, Pin-Shin, Jan, Hau-Ming, Yang, Tsai-Chen, Hsieh, Ming-Yen, Lee, Kung-Ta, Lin, Chun-Hung, Chen, Rita P-Y
Publicado 2022

High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study

por Yu, Ming-Lung, Dai, Chia-Yen, Chen, Shinn-Cherng, Lee, Li-Po, Hsieh, Ming-Yen, Lin, Zu-Yau, Hsieh, Ming-Yuh, Wang, Liang-Yen, Tsai, Jung-Fa, Chang, Wen-Yu, Chuang, Wan-Long
Publicado 2005

Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients

por Yeh, Ming-Lun, Peng, Cheng-Yuan, Dai, Chia-Yen, Lai, Hsueh-Chou, Huang, Chung-Feng, Hsieh, Ming-Yen, Huang, Jee-Fu, Chen, Shinn-Cherng, Lin, Zu-Yau, Yu, Ming-Lung, Chuang, Wan-Long
Publicado 2015

PNPLA3 genetic variants determine hepatic steatosis in non-obese chronic hepatitis C patients

por Huang, Chung-Feng, Chen, Jyh-Jou, Yeh, Ming-Lun, Huang, Ching-I, Hsieh, Ming-Yen, Yang, Hua-Ling, Dai, Chia-Yen, Huang, Jee-Fu, Lin, Zu-Yau, Chen, Shinn-Cherng, Chuang, Wan-Long, Chen, Yao-Li, Yu, Ming-Lung
Publicado 2015

Hyperuricemia Inversely Correlates with Disease Severity in Taiwanese Nonalcoholic Steatohepatitis Patients

por Huang, Jee-Fu, Yeh, Ming-Lun, Yu, Ming-Lung, Huang, Chung-Feng, Dai, Chia-Yen, Hsieh, Ming-Yen, Hsieh, Meng-Hsuan, Huang, Ching-I, Lin, Zu-Yau, Chen, Shinn-Chern, Hsiao, Pi-Jung, Shin, Shyi-Jang, Chuang, Wan-Long
Publicado 2015

Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis C

por Yeh, Ming-Lun, Huang, Ching-I, Huang, Chung-Feng, Hsieh, Meng-Hsuan, Hsieh, Ming-Yen, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Kuo, Po-Lin, Kuo, Hsing-Tao, Dai, Chia-Yen, Yu, Ming-Lung, Chuang, Wan-Long
Publicado 2018

Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study

por Huang, Chung-Feng, Yeh, Ming-Lun, Huang, Ching-I, Liang, Po-Cheng, Lin, Yi-Hung, Hsieh, Ming-Yen, Wei, Yu-Ju, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Dai, Chia-Yen, Chuang, Wan-Long, Yu, Ming-Lung
Publicado 2019

Virological Predictors of Response to Retreatment in Hepatitis C Genotype 2 Infected Patients

por Huang, Chung-Feng, Dai, Chia-Yen, Yeh, Ming-Lun, Huang, Jee-Fu, Huang, Ching-I, Hsieh, Ming-Yen, Lin, Zu-Yau, Chen, Shinn-Cherng, Wang, Liang-Yen, Juo, Suh-Hang Hank, Chuang, Wan-Long, Lin, Yi-Ching, Yu, Ming-Lung
Publicado 2013

Hepatitis C Virus Infection among Injection Drug Users with and without Human Immunodeficiency Virus Co-Infection

por Hsieh, Meng-Hsuan, Tsai, Jih-Jin, Hsieh, Ming-Yen, Huang, Chung-Feng, Yeh, Ming-Lun, Yang, Jeng-Fu, Chang, Ko, Lin, Wei-Ru, Lin, Chun-Yu, Chen, Tun-Chieh, Huang, Jee-Fu, Dai, Chia-Yen, Yu, Ming-Lung, Chuang, Wan-Long
Publicado 2014

Persistent cryoglobulinemia after antiviral treatment is associated with advanced fibrosis in chronic hepatitis C patients

por Batsaikhan, Batbold, Huang, Ching-I., Yeh, Ming-Lun, Huang, Chung-Feng, Lin, Yi-Hung, Liang, Po-Cheng, Hsieh, Ming-Yen, Lin, Yi-Ching, Huang, Jee-Fu, Chuang, Wan-Long, Lee, Jin-Ching, Yu, Ming-Lung, Kuo, Hsing-Tao, Dai, Chia-Yen
Publicado 2022

Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized Study

por Yeh, Ming-Lun, Hsieh, Ming-Yen, Huang, Ching-I., Huang, Chung-Feng, Hsieh, Meng-Hsuan, Liang, Po-Cheng, Lin, Yi-Hung, Hou, Nai-Jen, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Dai, Chia-Yen, Chuang, Wan-Long, Yu, Ming-Lung
Publicado 2015

The IL-6/STAT3 pathway upregulates microRNA-125b expression in hepatitis C virus infection

por Dai, Chia-Yen, Tsai, Yi-Shan, Chou, Wen-Wen, Liu, Tawei, Huang, Chung-Feng, Wang, Shu-Chi, Tsai, Pei-Chien, Yeh, Ming-Lun, Hsieh, Ming-Yen, Huang, Ching-I, Vanson Liu, Shang-Yin, Huang, Jee-Fu, Chuang, Wan-Long, Yu, Ming-Lung
Publicado 2018

Towards a safe hospital: hepatitis C in-hospital micro-elimination program (HCV-HELP study)

por Huang, Jee-Fu, Hsieh, Ming-Yen, Wei, Yu-Ju, Hung, Jen-Yu, Huang, Hsuan-Ti, Huang, Ching-I, Yeh, Ming-Lun, Huang, Chung-Feng, Jang, Tyng-Yuan, Hsu, Po-Yao, Liang, Po-Cheng, Dai, Chia-Yen, Lin, Zu-Yau, Yu, Ming-Lung, Chuang, Wan-Long
Publicado 2021

Elevated on-treatment levels of serum IFN-gamma is associated with treatment failure of peginterferon plus ribavirin therapy for chronic hepatitis C

por Lu, Ming-Ying, Huang, Ching-I, Dai, Chia-Yen, Wang, Shu-Chi, Hsieh, Ming-Yen, Hsieh, Meng-Hsuan, Liang, Po-Cheng, Lin, Yi-Hung, Hou, Nai-Jen, Yeh, Ming-Lun, Huang, Chung-Feng, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Chuang, Wan-Long, Yu, Ming-Lung
Publicado 2016

Huge Gap Between Clinical Efficacy and Community Effectiveness in the Treatment of Chronic Hepatitis C: A Nationwide Survey in Taiwan

por Yu, Ming-Lung, Yeh, Ming-Lun, Tsai, Pei-Chien, Huang, Ching-I., Huang, Jee-Fu, Huang, Chung-Feng, Hsieh, Meng-Hsuan, Liang, Po-Cheng, Lin, Yi-Hung, Hsieh, Ming-Yen, Lin, Wen-Yi, Hou, Nai-Jen, Lin, Zu-Yau, Chen, Shinn-Cherng, Dai, Chia-Yen, Chuang, Wan-Long, Chang, Wen-Yu
Publicado 2015

Itemization difference of patient-reported outcome in patients with chronic liver disease

por Lin, Ming-Chieh, Dai, Chia-Yen, Huang, Chung-Feng, Yeh, Ming-Lun, Liu, Yi-Chan, Hsu, Po-Yao, Wei, Yu-Ju, Lee, Pei-Lun, Huang, Ching-I, Liang, Po-Cheng, Hsieh, Ming-Yen, Hsieh, Meng-Hsuan, Jang, Tyng-Yuan, Lin, Zu-Yau, Huang, Jee-Fu, Yu, Ming-Lung, Chuang, Wan-Long
Publicado 2022